세계의 대규모 및 소규모 바이오프로세스 시장 보고서(2025년)

Large and small-scale bioprocessing are critical facets of the biotechnology and pharmaceutical sectors, employing living cells or their components to produce desired outputs such as pharmaceuticals, chemicals, and biofuels. Large-scale bioprocessing denotes the industrial-level manufacturing of biological products, utilizing large bioreactors and substantial infrastructure. Conversely, small-scale bioprocessing entails the production of biological products on a smaller scale, often for research, development, pilot studies, or specialized markets.

The primary products of both large and small-scale bioprocessing encompass bioreactors or fermenters, cell culture items, filtration assemblies, bioreactor accessories, bags, containers, and others. Bioreactors, also known as fermenters, are vessels engineered to facilitate the growth and metabolic processes of microorganisms or cells under controlled conditions to yield desired biological outputs. They are utilized through various modalities, including in-house and outsourced, and cater to several workflows, predominantly downstream processing, fermentation, and upstream processing. These products find application across a range of scales, from industrial to small-scale, and are employed in diverse sectors such as biopharmaceuticals, specialty industrial chemicals, and environmental aids.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The large and small-scale bioprocessing market research report is one of a series of new reports from The Business Research Company that provides large and small-scale bioprocessing market statistics, including large and small-scale bioprocessing industry global market size, regional shares, competitors with a large and small-scale bioprocessing market share, detailed large and small-scale bioprocessing market segments, market trends and opportunities, and any further data you may need to thrive in the large and small-scale bioprocessing industry. This large and small-scale bioprocessing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The large and small-scale bioprocessing market size has grown rapidly in recent years. It will grow from $59.63 billion in 2024 to $67.66 billion in 2025 at a compound annual growth rate (CAGR) of 13.5%. The growth in the historic period can be attributed to medical industry growth, regulatory standards, technological advancements, pharmaceutical and biotechnology growth, and food safety concerns.

The large and small-scale bioprocessing market size is expected to see rapid growth in the next few years. It will grow to $108.81 billion in 2029 at a compound annual growth rate (CAGR) of 12.6%. The growth in the forecast period can be attributed to increasing healthcare expenditure, the expansion of pharmaceutical and biotechnology sectors, technological innovations, regulatory pressures, rising awareness of food safety, and the aftermath of the COVID-19 pandemic. Major trends in the forecast period include the adoption of advanced technologies, geographical expansion, outsourcing of sterilization services, sustainable practices, hybrid sterilization techniques, and customized sterilization solutions.

The forecast of 12.6% growth over the next five years reflects a modest reduction of 0.8% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. biopharmaceutical manufacturers by driving up the cost of single-use bioreactors and filtration systems imported from Sweden and Singapore, exacerbating drug production delays and increasing biologics development expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing demand for biologics is poised to drive the expansion of the large and small-scale bioprocessing market in the future. Biologics encompass medicinal products derived from living organisms or their components, including vaccines, blood and blood components, gene therapies, tissues, and recombinant therapeutic proteins. The escalating demand for biologics is attributed to advancements in biotechnology, enhanced understanding of disease mechanisms, and the desire for targeted and personalized therapies. Both large-scale and small-scale bioprocessing play vital roles in the successful development and commercialization of biologics. Small-scale bioprocessing is crucial for early-stage development, optimization, and feasibility studies, whereas large-scale bioprocessing ensures efficient, consistent, and regulatory-compliant production of biologics for commercial distribution. For instance, in February 2024, according to the National Library of Medicine, a US-based medical library, the Food and Drug Administration (FDA) approved 55 new drugs in 2023, including 29 new chemical entities (NCEs) and 25 new biological entities (NBEs), marking a 50% increase compared to the 37 approvals in 2022. Hence, the growing demand for biologics is a driving force behind the growth of the large and small-scale bioprocessing market.

Key players in the large and small-scale bioprocessing market are innovating their product offerings, such as introducing single-use centrifuge systems, to provide customers with enhanced features. Single-use centrifuge systems are disposable and pre-sterilized devices designed for the separation of biological materials in bioprocessing. For instance, in September 2022, Thermo Fisher Scientific Inc., a US-based biotechnology company, unveiled the DynaSpin Single-Use Centrifuge system. This system aims to enhance large-scale cell culture harvesting by simplifying the separation process, reducing the need for depth filtration cartridges, and delivering advantages such as improved product yield, operational efficiency, cost savings, and sustainable practices in biologics production. The DynaSpin system contributes to cost reduction in production and supports sustainability objectives by significantly reducing material usage and waste compared to traditional harvest systems.

In December 2022, Merck KGaA, a German science and technology company, purchased Erbi Biosystems for an undisclosed sum. This acquisition bolsters Merck's portfolio in upstream therapeutic proteins, facilitating scalable cell-based perfusion bioreactor processes spanning from 2 milliliters (mL) to 2000 liters (L). Erbi Biosystems, based in the US, offers a range of bioprocessing solutions catering to both large and small-scale applications.

Major companies operating in the large and small-scale bioprocessing market are F. Hoffmann-La Roche AG, Merck & Co. Inc., Bayer AG, Sanofi S.A., Bristol Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca PLC, Novartis AG, GlaxoSmithKline PLC, 3M Company, Takeda Pharmaceutical Company Ltd., Danaher Corporation, Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Becton Dickinson and Company (BD), Teva Pharmaceutical Industries Ltd., DAIICHI SANKYO COMPANY LIMITED, Lonza Group, Sun Pharmaceutical Industries Ltd., GE Healthcare Life Sciences, Sartorius AG, Dr. Reddy's Laboratories Ltd., Alkem Laboratories Limited, Piramal Enterprises Ltd

North America was the largest region in the large and small-scale bioprocessing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the large and small-scale bioprocessing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the large and small-scale bioprocessing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The large and small-scale bioprocessing market consists of revenues earned by entities by providing plant cell bioprocessing, microbial bioprocessing, animal cell bioprocessing, and algal bioprocessing. The market value includes the value of related goods sold by the service provider or included within the service offering. The large and small-scale bioprocessing market also includes sales of shakers, incubators, and cell culture media. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Large And Small-Scale Bioprocessing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on large and small-scale bioprocessing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for large and small-scale bioprocessing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The large and small-scale bioprocessing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Bioreactors Or Fermenters; Cell Culture Products; Filtration Assemblies; Bioreactors Accessories; Bags And Containers; Other Products
• 2) By Mode: In-house; Outsourced
• 3) By Workflow: Downstream Processing; Fermentation; Upstream Processing
• 4) By Scale: Industrial Scale; Small Scale
• 5) By Application: Biopharmaceuticals; Specialty Industrial Chemicals; Environmental Aids
• Subsegments:
• 1) Bioreactors Or Fermenters: Single-Use Bioreactors; Stainless Steel Bioreactors; Glass Bioreactors
• 2) Cell Culture Products: Cell Culture Media; Sera And Supplements; Reagents
• 3) Filtration Assemblies: Membrane Filters; Depth Filters; Tangential Flow Filtration Systems
• 4) Bioreactor Accessories: Spargers; Impellers; Sensors And Probes
• 5) Bags And Containers: Single-Use Bags; Storage Containers; Transfer Bags
• 6) Other Products: Mixers; Tubing And Connectors; Sampling Systems
• Companies Mentioned: F. Hoffmann-La Roche AG; Merck & Co. Inc.; Bayer AG; Sanofi S.A.; Bristol Myers Squibb Company; Thermo Fisher Scientific Inc.; AstraZeneca PLC; Novartis AG; GlaxoSmithKline PLC; 3M Company; Takeda Pharmaceutical Company Ltd.; Danaher Corporation; Boehringer Ingelheim International GmbH; Novo Nordisk A/S; Becton Dickinson and Company (BD); Teva Pharmaceutical Industries Ltd.; Daiichi Sankyo Company; Lonza Group; Sun Pharmaceutical Industries Ltd.; GE Healthcare Life Sciences; Sartorius AG; Dr. Reddy's Laboratories Ltd.; Alkem Laboratories Limited; Piramal Enterprises Ltd
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Large And Small-Scale Bioprocessing Market Characteristics

3. Large And Small-Scale Bioprocessing Market Trends And Strategies

4. Large And Small-Scale Bioprocessing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Large And Small-Scale Bioprocessing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Large And Small-Scale Bioprocessing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Large And Small-Scale Bioprocessing Market Growth Rate Analysis
• 5.4. Global Large And Small-Scale Bioprocessing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Large And Small-Scale Bioprocessing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Large And Small-Scale Bioprocessing Total Addressable Market (TAM)

6. Large And Small-Scale Bioprocessing Market Segmentation

• 6.1. Global Large And Small-Scale Bioprocessing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bioreactors Or Fermenters
• Cell Culture Products
• Filtration Assemblies
• Bioreactors Accessories
• Bags And Containers
• Other Products
• 6.2. Global Large And Small-Scale Bioprocessing Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• In-house
• Outsourced
• 6.3. Global Large And Small-Scale Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Downstream Processing
• Fermentation
• Upstream Processing
• 6.4. Global Large And Small-Scale Bioprocessing Market, Segmentation By Scale, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Industrial Scale
• Small Scale
• 6.5. Global Large And Small-Scale Bioprocessing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biopharmaceuticals
• Specialty Industrial Chemicals
• Environmental Aids
• 6.6. Global Large And Small-Scale Bioprocessing Market, Sub-Segmentation Of Bioreactors Or Fermenters, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-Use Bioreactors
• Stainless Steel Bioreactors
• Glass Bioreactors
• 6.7. Global Large And Small-Scale Bioprocessing Market, Sub-Segmentation Of Cell Culture Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cell Culture Media
• Sera And Supplements
• Reagents
• 6.8. Global Large And Small-Scale Bioprocessing Market, Sub-Segmentation Of Filtration Assemblies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Membrane Filters
• Depth Filters
• Tangential Flow Filtration Systems
• 6.9. Global Large And Small-Scale Bioprocessing Market, Sub-Segmentation Of Bioreactor Accessories, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Spargers
• Impellers
• Sensors And Probes
• 6.10. Global Large And Small-Scale Bioprocessing Market, Sub-Segmentation Of Bags And Containers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-Use Bags
• Storage Containers
• Transfer Bags
• 6.11. Global Large And Small-Scale Bioprocessing Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mixers
• Tubing And Connectors
• Sampling Systems

7. Large And Small-Scale Bioprocessing Market Regional And Country Analysis

• 7.1. Global Large And Small-Scale Bioprocessing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Large And Small-Scale Bioprocessing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Large And Small-Scale Bioprocessing Market

• 8.1. Asia-Pacific Large And Small-Scale Bioprocessing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Large And Small-Scale Bioprocessing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Large And Small-Scale Bioprocessing Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Large And Small-Scale Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Large And Small-Scale Bioprocessing Market

• 9.1. China Large And Small-Scale Bioprocessing Market Overview
• 9.2. China Large And Small-Scale Bioprocessing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Large And Small-Scale Bioprocessing Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Large And Small-Scale Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Large And Small-Scale Bioprocessing Market

• 10.1. India Large And Small-Scale Bioprocessing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Large And Small-Scale Bioprocessing Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Large And Small-Scale Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Large And Small-Scale Bioprocessing Market

• 11.1. Japan Large And Small-Scale Bioprocessing Market Overview
• 11.2. Japan Large And Small-Scale Bioprocessing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Large And Small-Scale Bioprocessing Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Large And Small-Scale Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Large And Small-Scale Bioprocessing Market

• 12.1. Australia Large And Small-Scale Bioprocessing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Large And Small-Scale Bioprocessing Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Large And Small-Scale Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Large And Small-Scale Bioprocessing Market

• 13.1. Indonesia Large And Small-Scale Bioprocessing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Large And Small-Scale Bioprocessing Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Large And Small-Scale Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Large And Small-Scale Bioprocessing Market

• 14.1. South Korea Large And Small-Scale Bioprocessing Market Overview
• 14.2. South Korea Large And Small-Scale Bioprocessing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Large And Small-Scale Bioprocessing Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Large And Small-Scale Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Large And Small-Scale Bioprocessing Market

• 15.1. Western Europe Large And Small-Scale Bioprocessing Market Overview
• 15.2. Western Europe Large And Small-Scale Bioprocessing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Large And Small-Scale Bioprocessing Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Large And Small-Scale Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Large And Small-Scale Bioprocessing Market

• 16.1. UK Large And Small-Scale Bioprocessing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Large And Small-Scale Bioprocessing Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Large And Small-Scale Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Large And Small-Scale Bioprocessing Market

• 17.1. Germany Large And Small-Scale Bioprocessing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Large And Small-Scale Bioprocessing Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Large And Small-Scale Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Large And Small-Scale Bioprocessing Market

• 18.1. France Large And Small-Scale Bioprocessing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Large And Small-Scale Bioprocessing Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Large And Small-Scale Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Large And Small-Scale Bioprocessing Market

• 19.1. Italy Large And Small-Scale Bioprocessing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Large And Small-Scale Bioprocessing Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Large And Small-Scale Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Large And Small-Scale Bioprocessing Market

• 20.1. Spain Large And Small-Scale Bioprocessing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Large And Small-Scale Bioprocessing Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Large And Small-Scale Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Large And Small-Scale Bioprocessing Market

• 21.1. Eastern Europe Large And Small-Scale Bioprocessing Market Overview
• 21.2. Eastern Europe Large And Small-Scale Bioprocessing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Large And Small-Scale Bioprocessing Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Large And Small-Scale Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Large And Small-Scale Bioprocessing Market

• 22.1. Russia Large And Small-Scale Bioprocessing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Large And Small-Scale Bioprocessing Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Large And Small-Scale Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Large And Small-Scale Bioprocessing Market

• 23.1. North America Large And Small-Scale Bioprocessing Market Overview
• 23.2. North America Large And Small-Scale Bioprocessing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Large And Small-Scale Bioprocessing Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Large And Small-Scale Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Large And Small-Scale Bioprocessing Market

• 24.1. USA Large And Small-Scale Bioprocessing Market Overview
• 24.2. USA Large And Small-Scale Bioprocessing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Large And Small-Scale Bioprocessing Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Large And Small-Scale Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Large And Small-Scale Bioprocessing Market

• 25.1. Canada Large And Small-Scale Bioprocessing Market Overview
• 25.2. Canada Large And Small-Scale Bioprocessing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Large And Small-Scale Bioprocessing Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Large And Small-Scale Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Large And Small-Scale Bioprocessing Market

• 26.1. South America Large And Small-Scale Bioprocessing Market Overview
• 26.2. South America Large And Small-Scale Bioprocessing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Large And Small-Scale Bioprocessing Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Large And Small-Scale Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Large And Small-Scale Bioprocessing Market

• 27.1. Brazil Large And Small-Scale Bioprocessing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Large And Small-Scale Bioprocessing Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Large And Small-Scale Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Large And Small-Scale Bioprocessing Market

• 28.1. Middle East Large And Small-Scale Bioprocessing Market Overview
• 28.2. Middle East Large And Small-Scale Bioprocessing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Large And Small-Scale Bioprocessing Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Large And Small-Scale Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Large And Small-Scale Bioprocessing Market

• 29.1. Africa Large And Small-Scale Bioprocessing Market Overview
• 29.2. Africa Large And Small-Scale Bioprocessing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Large And Small-Scale Bioprocessing Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Large And Small-Scale Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Large And Small-Scale Bioprocessing Market Competitive Landscape And Company Profiles

• 30.1. Large And Small-Scale Bioprocessing Market Competitive Landscape
• 30.2. Large And Small-Scale Bioprocessing Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bristol Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

31. Large And Small-Scale Bioprocessing Market Other Major And Innovative Companies

• 31.1. Thermo Fisher Scientific Inc.
• 31.2. AstraZeneca PLC
• 31.3. Novartis AG
• 31.4. GlaxoSmithKline PLC
• 31.5. 3M Company
• 31.6. Takeda Pharmaceutical Company Ltd.
• 31.7. Danaher Corporation
• 31.8. Boehringer Ingelheim International GmbH
• 31.9. Novo Nordisk A/S
• 31.10. Becton Dickinson and Company (BD)
• 31.11. Teva Pharmaceutical Industries Ltd.
• 31.12. Daiichi Sankyo Company
• 31.13. Lonza Group
• 31.14. Sun Pharmaceutical Industries Ltd.
• 31.15. GE Healthcare Life Sciences

32. Global Large And Small-Scale Bioprocessing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Large And Small-Scale Bioprocessing Market

34. Recent Developments In The Large And Small-Scale Bioprocessing Market

35. Large And Small-Scale Bioprocessing Market High Potential Countries, Segments and Strategies

• 35.1 Large And Small-Scale Bioprocessing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Large And Small-Scale Bioprocessing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Large And Small-Scale Bioprocessing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer